CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE. GCM [Internet]. 2026 Sep. 12 [cited 2026 Oct. 30];1(9):29-36. Available from: https://www.econferencia.com/index.php/5/article/view/1409